Related Experiment Video
Updated: Jun 19, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Intravenous thrombolysis in stroke attributable to cervical artery dissection
Stefan T Engelter1, Matthieu P Rutgers, Florian Hatz
1Stroke Units and Department of Neurology, University Hospitals Basel, Switzerland. sengelter@uhbs.ch
Insights
Intravenous thrombolysis (IVT) for cervical artery dissection (CAD) shows less favorable outcomes compared to other stroke causes. However, similar rates of bleeding and recurrent stroke suggest IVT remains a viable treatment option for CAD patients.
Area of Science:
- Neurology
- Vascular Medicine
- Emergency Medicine
Background:
- Cervical artery dissection (CAD) is a significant cause of stroke in younger adults.
- The efficacy and safety of intravenous thrombolysis (IVT) in CAD patients remain under investigation.
- Previous studies suggest IVT benefits stroke patients regardless of etiology.
Purpose of the Study:
- To evaluate the outcomes and complications of IVT in patients with CAD compared to non-CAD stroke patients.
- To determine if IVT is a safe and effective treatment for stroke secondary to CAD.
- To identify factors contributing to potential differences in outcomes.
Main Methods:
- Retrospective analysis of the Swiss IVT databank.
- Comparison of IVT-treated CAD patients (n=55) with non-CAD patients (n=1007).
- Primary outcomes included favorable 3-month outcome (modified Rankin Scale score ≤1), intracranial hemorrhage, and recurrent ischemic stroke.
Main Results:
- CAD patients were younger but had similar stroke severity and treatment times compared to non-CAD patients.
- Favorable 3-month outcome was less frequent in CAD patients (36%) versus non-CAD patients (44%), particularly after age, gender, and NIHSS adjustment (OR, 0.50; P=0.03).
- Rates of intracranial hemorrhage (14% vs. 14%) and recurrent ischemic stroke (1.8% vs. 3.7%) were similar between CAD and non-CAD groups.
Conclusions:
- IVT-treated CAD patients experience less favorable functional recovery compared to non-CAD patients.
- The similar rates of intracranial hemorrhage and recurrent ischemic stroke suggest these complications do not explain the outcome disparity.
- IVT should not be withheld from patients with suspected CAD, as potential factors like hemodynamic compromise or tandem occlusions may influence outcomes.
Background And Purpose:
Intravenous thrombolysis (IVT) for stroke seems to be beneficial independent of the underlying etiology. Whether this is also true for cervical artery dissection (CAD) is addressed in this study.
Methods:
We used the Swiss IVT databank to compare outcome and complications of IVT-treated patients with CAD with IVT-treated patients with other etiologies (non-CAD patients). Main outcome and complication measures were favorable 3-month outcome, intracranial cerebral hemorrhage, and recurrent ischemic stroke. Modified Rankin Scale score
Results:
Fifty-five (5.2%) of 1062 IVT-treated patients had CAD. Patients with CAD were younger (median age 50 versus 70 years) but had similar median National Institutes of Health Stroke Scale scores (14 versus 13) and time to treatment (152.5 versus 156 minutes) as non-CAD patients. In the CAD group, 36% (20 of 55) had a favorable 3-month outcome compared with 44% (447 of 1007) non-CAD patients (OR, 0.72; 95% CI, 0.41 to 1.26), which was less favorable after adjustment for age, gender, and National Institutes of Health Stroke Scale score (OR, 0.50; 95% CI, 0.27 to 0.95; P=0.03). Intracranial cerebral hemorrhages (asymptomatic, symptomatic, fatal) were equally frequent in CAD (14% [7%, 7%, 2%]) and non-CAD patients (14% [9%, 5%, 2%]; P=0.99). Recurrent ischemic stroke occurred in 1.8% of patients with CAD and in 3.7% of non-CAD-patients (P=0.71).
Conclusions:
IVT-treated patients with CAD do not recover as well as IVT-treated non-CAD patients. However, intracranial bleedings and recurrent ischemic strokes were equally frequent in both groups. They do not account for different outcomes and indicate that IVT should not be excluded in patients who may have CAD. Hemodynamic compromise or frequent tandem occlusions might explain the less favorable outcome of patients with CAD.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Transient Ischemic Attack l: Introduction
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction

